uOmnispace.MR vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
uOmnispace.MR
by Shanghai United Imaging Healthcare Co., Ltd.
VS
Zio AT ECG Monitoring System
by iRhythm Technologies, Inc.

AI Verdict

While both tools leverage AI in cardiology, they serve distinct purposes and utilize different data types. uOmnispace.MR focuses on advanced analysis of magnetic resonance (MR) images for comprehensive cardiac diagnostics, including structural and functional assessments. In contrast, the Zio AT ECG Monitoring System provides continuous, AI-powered wearable ECG monitoring for long-term arrhythmia detection and reporting.

Choose uOmnispace.MR if…

Choose uOmnispace.MR if your clinical practice requires advanced, AI-powered post-processing and in-depth analysis of magnetic resonance (MR) images across multiple specialties like neurology, cardiology, and oncology. This tool is ideal for detailed diagnostic evaluation, including AI-driven segmentation of cardiac ventricles, perfusion analysis, and MR spectroscopy, leveraging existing MR scan data.

View uOmnispace.MR →

Choose Zio AT ECG Monitoring System if…

Choose Zio AT ECG Monitoring System if you need a continuous, long-term, and remote solution for detecting cardiac arrhythmias in patients with intermittent symptoms or suspected transient events. This wearable mobile cardiac telemetry system is best suited for extended ECG monitoring (up to 14 days) with AI-powered detection and comprehensive reporting, enabling timely diagnosis and management of both symptomatic and asymptomatic cardiac events.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature uOmnispace.MR Zio AT ECG Monitoring System
Pricing Contact for pricing Contact for pricing
Deployment Software-only medical device; can run standalone or integrated with other cleared applications on standard off-the-shelf PCs; supports remote multi-user access on a network. The broader uOmnispace platform is available as SaaS, on-premise, or hybrid. Cloud-based (data analytics and clinician portal)
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio AT ECG Monitoring System

Tool B, the Zio AT ECG Monitoring System, offers a highly patient-centric and user-friendly experience with its wearable patch, wireless data transmission, and dedicated mobile apps for both patients and clinicians. This 'wear and forget' design, combined with intuitive apps, simplifies long-term cardiac monitoring for a broader user base.

Clinical Value

uOmnispace.MR

While both tools are FDA-cleared and provide significant clinical value, uOmnispace.MR (Tool A) offers a broader and deeper range of AI-powered diagnostic insights across multiple MR imaging modalities, including brain, breast, and cardiac applications. Its advanced post-processing tools, such as MR Spectroscopy and perfusion analysis, provide comprehensive diagnostic information.

Pricing & Value

Tie

Both tools require direct contact for pricing, and neither provides publicly disclosed pricing details or specific value propositions that would allow for a comparative assessment. While Tool B mentions service fees for monitoring and analysis, specific cost structures for both remain opaque.

Enterprise Readiness

uOmnispace.MR

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating enterprise readiness. However, uOmnispace.MR (Tool A) offers more flexible deployment options, including standalone, integrated, SaaS, on-premise, or hybrid models, and supports remote multi-user access, which caters to a wider range of institutional IT infrastructures and preferences.

Innovation

Zio AT ECG Monitoring System

The Zio AT ECG Monitoring System (Tool B) demonstrates greater innovation through its integrated approach to remote patient monitoring, combining a comfortable wearable patch, real-time wireless data transmission, and a deep-learned AI algorithm for continuous, long-term arrhythmia detection. This comprehensive ecosystem, including patient and clinician mobile apps, significantly advances patient engagement and continuous cardiac care delivery.

Support & Docs

Tie

Both Shanghai United Imaging Healthcare Co., Ltd. and iRhythm Technologies, Inc. are established medical device companies that provide customer support and documentation. United Imaging offers a global service network, technical support, and training, including an online document library. iRhythm provides support resources for clinicians and patients, including user manuals and FAQs on their website. Without more specific comparative details on the quality, breadth, or responsiveness of their support channels, it is difficult to definitively choose a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature uOmnispace.MR Zio AT ECG Monitoring System
Tool Name uOmnispace.MR Zio AT ECG Monitoring System
Company Shanghai United Imaging Healthcare Co., Ltd. iRhythm Technologies, Inc.
Primary Application AI-powered software for comprehensive magnetic resonance (MR) image analysis, supporting diverse clinical applications including brain, breast, and cardiac imaging with advanced post-processing tools and AI-driven segmentation. FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting.
Key Feature (AI Capability) AI-driven cardiac ventricular segmentation FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection
Key Feature (Monitoring/Analysis) MR image viewing, processing, and analysis; Stitching for full-format MR images; Dynamic studies analysis; MR Spectroscopy (SVS and CSI); Perfusion analysis (e.g., Brain Perfusion); Vessel analysis for MR vascular images; Cardiac function analysis. Wearable Zio AT patch for continuous ECG recording; Wireless gateway for real-time data transmission; Continuous, uninterrupted ECG recording for up to 14 days; Detection of symptomatic and asymptomatic cardiac events; Comprehensive end-of-wear reports for clinicians; ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation; MyZiou00ae patient mobile app for symptom logging and education.
Specialties Supported Cardiology, Neurology, Radiology Cardiology

Videos

Demos, reviews, and walkthroughs featuring uOmnispace.MR and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

uOmnispace.MR is designed for post-processing and analysis of acquired MR images, fitting into a radiology or cardiology reading workflow to enhance diagnostic capabilities for brain, breast, and cardiac studies. Zio AT provides a wearable solution for continuous ECG monitoring, integrating into an outpatient cardiology workflow for long-term arrhythmia detection and management, with its ZioSuite portal simplifying patient management and report interpretation.
uOmnispace.MR communicates with various imaging and hospital information systems through the DICOM3.0 standard, allowing for image transfer and potentially structured reporting back into the EHR. Zio AT offers seamless EHR integration, including with Epic via the Aura network, enabling electronic order submission, patient registration, and automated delivery of comprehensive end-of-wear reports directly into the patient's chart.
uOmnispace.MR's AI for cardiac ventricular segmentation has demonstrated high consistency with a Dice coefficient of 1.00, and its deep learning algorithms for spine and rib labeling show high accuracy and robustness. Zio AT utilizes its FDA-cleared deep-learned AI (ZEUS System) for arrhythmia detection, with studies showing high sensitivity and specificity for AFib detection (e.g., 93.6% sensitivity and 99.1% specificity for AFib Context Engine algorithm) and 99% physician agreement with end-of-wear reports.
uOmnispace.MR, with its advanced post-processing features for various MR applications, may require some training for optimal use of its specialized analysis tools. The Zio AT system, including its ZioSuite clinician portal and MyZio patient app, is designed for intuitive use, with the primary learning curve focused on interpreting comprehensive reports and managing the patient monitoring process.
uOmnispace.MR includes audit logs to track user activities and ensure traceability of image processing steps and analysis. For Zio AT, audit trails are maintained within the ZioSuite portal, tracking clinician access, patient data uploads, and report generation, which is crucial for regulatory compliance and clinical accountability.
For uOmnispace.MR, multi-site rollout involves software deployment on workstations or servers, licensing, and ensuring network infrastructure supports remote access and DICOM data transfer. Zio AT, as a cloud-based service, simplifies multi-site deployment by offering centralized access to the ZioSuite portal and supporting scalable EHR integration via HL7 or Epic Aura network, with considerations for patient enrollment workflows and report distribution.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring uOmnispace.MR or Zio AT ECG Monitoring System

Backers

Who funded each tool's parent company.

Zio AT ECG Monitoring System

AI Tool Finder
AI-powered search. Results may not be comprehensive.